Reaction
Basal Ganglia Infarction reporting signals
As of the last recalculation, Basal Ganglia Infarction appears in 343 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is SEVOFLURANE (PRR 75.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sevoflurane | 10 | 75.2 | 75.3 |
| Rasagiline Mesylate | 8 | 44.6 | 44.7 |
| Rivastigmine | 10 | 33.1 | 33.2 |
| Amantadine | 8 | 32.1 | 32.1 |
| Alteplase | 7 | 28.9 | 28.9 |
| Pyrazinamide | 4 | 26.1 | 26.1 |
| Romiplostim | 6 | 24.6 | 24.6 |
| Inclisiran | 3 | 22.9 | 22.9 |
| Drospirenone And Ethinyl Estradiol | 10 | 14.1 | 14.1 |